Litcius/Paper detail

Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins

Franziska Blaeschke, Dana Stenger, Antonia Apfelbeck, Bruno L. Cadilha, Mohamed-Reda Benmebarek, Jasmin Mahdawi, Eva Ortner, Mareike Lepenies, Nicola Habjan, Felicitas Rataj, Semjon Willier, Theresa Kaeuferle, Robbie G. Majzner, Dirk H. Busch, Sebastian Kobold, Tobias Feuchtinger

2021Blood Cancer Journal28 citationsDOIOpen Access PDF

Topics & Concepts

CD22CD19CD28Function (biology)Fusion proteinT cellMedicineImmunologyCancer researchComputational biologyVirologyBiologyCell biologyGeneticsAntigenImmune systemGeneRecombinant DNACAR-T cell therapy researchNanowire Synthesis and ApplicationsAdvancements in Semiconductor Devices and Circuit Design
Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins | Litcius